Table 3.
Group-1 (n=352) | Group-2 (n=104) | p | |
---|---|---|---|
Age | 69.45±11.06 | 65.69±15.38 | 0.261 |
Gender (%) | 0.789 | ||
Female | 37.5 | 34.6 | |
Male | 72.5 | 65.4 | |
BMI | 24.2±2.75 | 23.8±2.56 | 0.856 |
GH (<1 ng/ml) | 0.125±0.88 | 0.238±0.194 | 0.000 |
IGF-1(ng/ml) | 55.05±23.3 | 104.08±31.46 | 0.000 |
AST (7–40 U/L) | 23.83±9.14 | 23.03±12.89 | 0.715 |
ALT (7–40 U/L) | 27.30±11.20 | 28.53±21.98 | 0.785 |
GFR | 80.31±22.70 | 81.42±24.64 | 0.831 |
Creatinine (<1 mg/dl) | 0.96±0.34 | 0.94±0.28 | 0.841 |
Glucose (70–100 mg/dl) | 118.57±19.59 | 107.46±14.94 | 0.848 |
HBA1C (<6.5%) | 6.75±1.46 | 6.24±0.80 | 0.880 |
CRP (<5 mg/L) | 90.72±62.42 | 50.0±67.09 | 0.006 |
Hospital stay | 8.80±2.14 | 4.75±1.25 | 0.002 |
BMI: Body mass index; GH: Growth hormone; IGF-I: Insulin-like growth factor-I; HbA1c: Glycosylated hemoglobin; ALT: Alanine amino transferase; AST: Aspartate amino transferase; BUN: Blood urea nitrogen; eGFR: Estimated glomerular filtration rate; CRP: C reactive protein.